Health Secretary promoting wearables and CGMs, boosting stocks of Abbott Laboratories and DexCom

From Yahoo Finance.: 2025-07-01 09:00:00

U.S. Health and Human Services Secretary Robert F. Kennedy Jr. is launching a major advertising campaign to promote wearables and continuous glucose monitors (CGMs) for public health. Stocks of companies like Abbott Laboratories and DexCom have surged following his comments, with potential for significant growth and healthier lifestyles.

Abbott Laboratories dominates the global CGM market with its FreeStyle Libre platform, reporting strong revenue growth and targeting $10 billion in annual sales related to Libre devices by 2028. Positive real-world studies support its wearables’ benefits, which could see a boost from government subsidies.

Dexcom offers CGM products like the Dexcom G7 and Stelo, attracting a substantial number of subscribers. With a revenue growth forecast of 14%, the company is poised for growth if the government supports wearables. Stock prices have seen a recent uptick following Kennedy’s remarks.



Read more at Yahoo Finance.: 2 ‘Strong Buy’ Stocks That the MAHA Movement AND Wall Street Love